Other common activities reported include recommendations related to high-risk AG-014699 molecular weight groups, vaccine formulation, research priorities, and implications of adverse events. Other less commonly reported topics for which committees issue recommendations include those for vaccine coverage, logistics, supply, and regulation; supplementary immunization activities (for example, activities associated with polio eradication); vaccine and immunization program financing; and

communicable or vaccine preventable disease surveillance, control, or outbreak response. Additional activities include responding to questions from key groups or the public and educational efforts related to vaccines and immunization. The process of committee member nomination is diverse. The broadest recruitment process is used by countries like the United States and United Kingdom, which advertise nationally and accept nominations from any source. In France, nominations come through the general medical community. In four countries, members are selected based on positions allocated to the central government or professional organizations. In the case of the former, members serve as long as they remain in their position and in the case of the latter they are nominated by the organization. For the Regorafenib cell line remaining five countries for

whom this information is known, the MOH, the NITAG itself, or both put forward nominations. Regardless of the nomination process, MOH representatives play a central role on almost all the committees, either by the virtue of holding the position of chairperson or secretary, holding various fixed positions, or acting as the committee secretariat. In some instances, numerous MOH agencies (including regulatory) have committee representation. Expertise represented on the committees is primarily medical or public health and includes paediatricians, family practitioners, infectious disease

experts, experts on vaccinology or immunization, public health experts, and in rare cases economists. Community representation was included on four committees: a consumer representative in South Korea and the United States, a consumer expert in Australia, and a “lay person” in the United Kingdom. Appointment to committees varies from 2 years to unlimited, for example, positions assigned to specific government positions. The most common duration is 4 years, and usually reappointment is allowed (either a limited or indefinite number of times). Korea, with the shortest period of appointment at 2 years, does not allow reappointment nor does the United States. The total number of official committee members that vote or participate in consensus decisions (depending on the decision-making process) varies from 5 in Honduras (all paediatricians) and 10 in Oman to 33 in India and 38 in Sri Lanka. The median number is 19.